TFM
NUVB icon

TFC Financial Management’s Nuvation Bio NUVB Stock Holding History

TFC Financial Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.38K Hold
1,300
– – ﹤0.01% 445
2026
Q1 		$5.58K Buy
1,300
+250
+24% +$1.39K ﹤0.01% 444
2025
Q4 		$9.41K Buy
1,050
+50
+5% +$310 ﹤0.01% 398
2025
Q3 		$3.7K Buy
1,000
+500
+100% +$1.36K ﹤0.01% 490
2025
Q2 		$975 Hold
500
– – ﹤0.01% 579
2025
Q1 		$880 Buy
500
+230
+85% +$524 ﹤0.01% 571
2024
Q4 		$719 Buy
+270
New +$695 ﹤0.01% 600

Other funds holding NUVB

Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $153M AUM
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.21B AUM 82.36% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return

TFC Financial Management's NUVB Position: Q2 2026 in Review

TFC Financial Management held its Nuvation Bio (NUVB) position steady in Q2 2026 at 1,300 shares worth $7.38K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

TFC Financial Management first reported a position in NUVB in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.41K in Q4 2025. 66 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • TFC Financial Management held 1,300 shares of Nuvation Bio worth $7.38K as of Q2 2026.
  • TFC Financial Management left its Nuvation Bio share count unchanged in Q2 2026.
  • Nuvation Bio made up ﹤0.01% of TFC Financial Management's portfolio in Q2 2026, its #445 holding.
  • TFC Financial Management first reported a position in Nuvation Bio in Q4 2024 and has held it in 7 quarters since.
  • TFC Financial Management's Nuvation Bio position peaked at $9.41K in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on TFC Financial Management's 13F filing for Q2 2026, filed 23 Jul 2026.